Drug Interaction Study of Gliclazide with Pravastatin and Gemfibrozil in Rats
Author Information
Author(s): Sultanpur CM, Satyanarayana S, Reddy NS, Kumar KE, Kumar S
Primary Institution: Government College of Pharmacy, Bangalore, India
Hypothesis
The study aims to evaluate the safety of gliclazide in the presence of pravastatin and gemfibrozil in rats.
Conclusion
The combination of gliclazide with pravastatin and gemfibrozil enhances the hypoglycemic effect and should be used with caution.
Supporting Evidence
- Gliclazide produced a maximum reduction of blood glucose levels at 2 and 8 hours.
- The combination treatment increased the hypoglycemic effect of gliclazide in both normal and diabetic rats.
- Pravastatin and gemfibrozil inhibit the metabolism of gliclazide, leading to enhanced effects.
Takeaway
This study looked at how a diabetes medicine works with two cholesterol medicines in rats, finding that they can make the diabetes medicine work better.
Methodology
The study involved administering gliclazide alone and in combination with pravastatin and gemfibrozil to normal and diabetic rats, followed by blood glucose analysis.
Limitations
The study was conducted only in rats, and results may not directly translate to humans.
Participant Demographics
Albino rats of either sex, weighing between 160 and 280 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website